Assyro AI

FDA Orange Book · active-ingredient family

Diethylstilbestrol

Diethylstilbestrol is approved as 4 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:STILBESTROL · NDA 004056

4

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, suppository, tablet, tablet, delayed release

ProductApplicantApplicationTEApproved
STILBESTROL×15BRISTOL MYERS SQUIBBNDA 004056Approved Prior to Jan 1, 1982
DIETHYLSTILBESTROL×2LILLYNDA 004040Approved Prior to Jan 1, 1982
DIETHYLSTILBESTROL×5LILLYNDA 004039Approved Prior to Jan 1, 1982
DIETHYLSTILBESTROL×4LILLYNDA 004041Approved Prior to Jan 1, 1982

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
STILBESTROLTABLICAPSANDA 083003Approved Prior to Jan 1, 1982
STILBESTROLTABLICAPSANDA 083005Approved Prior to Jan 1, 1982
STILBESTROLTABLICAPSANDA 083007Approved Prior to Jan 1, 1982
STILBESTROLTABLICAPSANDA 083004Approved Prior to Jan 1, 1982
STILBESTROLTABLICAPSANDA 083002Approved Prior to Jan 1, 1982
STILBESTROLTABLICAPSANDA 083006Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Diethylstilbestrol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.